Evidence map›Paper›PMID 42338518›Full record

ArticleESMO real world data and digital oncology2026

Development and evaluation of a large language model-based, retrieval-augmented generation application for query response in early oncology clinical trials.

D Pesántez, G Fucà, A Magrì, L Koulai, K Bliznashki, A Soltani, M Khan, F Multari, M Moschetta

Abstract read
In one paragraph

Article in ESMO real world data and digital oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

D PesántezOncology R&D, Early Oncology Clinical, AstraZeneca Barcelona Global Hub, Barcelona, Spain.
G FucàOncology R&D, Early Oncology Clinical, AstraZeneca Barcelona Global Hub, Barcelona, Spain.
A MagrìOncology R&D, Early Oncology Clinical, AstraZeneca Barcelona Global Hub, Barcelona, Spain.
L KoulaiOncology R&D, AstraZeneca, Cambridge, UK.
K BliznashkiEvinova, Human-Centered AI and Data Science, Gaithersburg, USA.
A SoltaniEvinova, Human-Centered AI and Data Science, Waltham, USA.
M KhanEvinova, Human-Centered AI and Data Science, Gaithersburg, USA.
F MultariEvinova, Human-Centered AI and Data Science, Barcelona, Spain.
M MoschettaOncology R&D, Early Oncology Clinical, AstraZeneca Barcelona Global Hub, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Early-phase oncology trials involve complex protocols and extensive documents, making timely resolution of study queries challenging. We developed the Study Document Assistant (SDA), a retrieval-augmented generation (RAG) system that integrates semantic search with large language models to generate context-specific answers from clinical trial documentation. Materials and methods: SDA processes study documents and delivers responses through a secure, conversational interface. A two-arm experiment was conducted in which sponsor clinical study team members answered protocol-related queries either with or without SDA. Questions were stratified by difficulty and assessed by blinded subject matter experts (SMEs) and artificial intelligence (AI) models. The primary endpoint was mean response time. Main secondary endpoints included response time as a time-to-event outcome and overall accuracy. SDA user satisfaction was also assessed. Data were analyzed using Welch Results: In the experiment ( Conclusions: Our findings demonstrate that SDA accelerates query resolution without compromising answer quality, highlighting the potential of RAG-based digital assistants to streamline clinical trial operations and enhance research efficiency.

Indexed as

clinical trialsdigital healthlarge language modeloncologyretrieval-augmented generationstudy document assistant

Identifiers

PMID42338518
PMCPMC13285752

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.